United States Interventional Cardiology Market Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast To 2020 GlobalData's new report, "United States Interventional Cardiology Market Outlook to 2020", provides key market data on the United States Interventional Cardiology market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Arteriotomy Closure Devices, Cardiac Catheters, Coronary Guidewires, Coronary Stents, Intravascular Ultrasound Systems (IVUS), PTCA Balloons and PTCA Coronary Drug Eluting Balloons (DEB). The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Interventional Cardiology market wherever available. The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. To Get More Details @ http://www.radiantinsights.com/research/united-statesinterventional-cardiology-market-outlook-to-2020 The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases). Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis. Scope - Market size for Interventional Cardiology categories - Arteriotomy Closure Devices, Cardiac Catheters, Coronary Guidewires, Coronary Stents, Intravascular Ultrasound Systems (IVUS), PTCA Balloons and PTCA Coronary Drug Eluting Balloons (DEB).
- Annualized market revenue (USD million), volume (units) and average selling price ($) data for the market categories. Data is provided from 2005 to 2012 and forecast to 2020. - 2012 company shares and distribution shares data for the market category. - Global corporate-level profiles of key companies operating within the United States Interventional Cardiology market. - Key players covered include Abbott Laboratories, Boston Scientific Corporation, Medtronic, Inc. and Cordis Corporation. Reasons to buy - Develop business strategies by identifying the key market categories and segments poised for strong growth in the future. - Develop market-entry and market expansion strategies. - Design competition strategies by identifying who-stands-where in the market. - Develop investment strategies by identifying the key market segments expected to register strong growth in the near future. - What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize. Table Of Content: 1 Table of Contents 2 1.1 List of Tables 9 1.2 List of Figures 11 Request Free Sample Of This Study @ http://www.radiantinsights.com/research/unitedstates-interventional-cardiology-market-outlook-to-2020#tabs-4 2 Introduction 12 2.1 What Is This Report About? 12 2.2 Interventional Cardiology Market Segmentation 12 2.3 Definitions of Markets Covered in the Report 13 3 Interventional Cardiology Market, United States 16 3.1 Interventional Cardiology Market, United States, Revenue ($m), 2005-2012 16 3.2 Interventional Cardiology Market, United States, Revenue ($m), 2012-2020 18 3.2.1 Arteriotomy Closure Devices Market, United States, Revenue ($m), by Segment, 20052012 20 3.2.2 Cardiac Catheters Market, United States, Revenue ($m), by Segment, 2005-2012 22 3.2.3 Coronary Stents Market, United States, Revenue ($m), by Segment, 2005-2012 24 3.2.4 Intravascular Ultrasound Systems (IVUS) Market, United States, Revenue ($m), by Segment, 2005-2012 26 3.2.5 PTCA Balloons Market, United States, Revenue ($m), by Segment, 2005-2012 28 3.2.6 Arteriotomy Closure Devices Market, United States, Revenue ($m), by Segment, 20122020 30
3.2.7 Cardiac Catheters Market, United States, Revenue ($m), by Segment, 2012-2020 32 3.2.8 Coronary Stents Market, United States, Revenue ($m), by Segment, 2012-2020 34 3.2.9 Intravascular Ultrasound Systems (IVUS) Market, United States, Revenue ($m), by Segment, 2012-2020 36 3.2.10 PTCA Balloons Market, United States, Revenue ($m), by Segment, 2012-2020 38 3.3 Interventional Cardiology Market, United States, Volume (Units), 2005-2012 40 3.4 Interventional Cardiology Market, United States, Volume (Units), 2012-2020 42 3.4.1 Arteriotomy Closure Devices Market, United States, Volume (Units), by Segment, 20052012 44 3.4.2 Cardiac Catheters Market, United States, Volume (Units), by Segment, 2005-2012 46 3.4.3 Coronary Stents Market, United States, Volume (Units), by Segment, 2005-2012 48 3.4.4 Intravascular Ultrasound Systems (IVUS) Market, United States, Volume (Units), by Segment, 2005-2012 50 3.4.5 PTCA Balloons Market, United States, Volume (Units), by Segment, 2005-2012 52 3.4.6 Arteriotomy Closure Devices Market, United States, Volume (Units), by Segment, 20122020 54 3.4.7 Cardiac Catheters Market, United States, Volume (Units), by Segment, 2012-2020 56 3.4.8 Coronary Stents Market, United States, Volume (Units), by Segment, 2012-2020 58 3.4.9 Intravascular Ultrasound Systems (IVUS) Market, United States, Volume (Units), by Segment, 2012-2020 60 3.4.10 PTCA Balloons Market, United States, Volume (Units), by Segment, 2012-2020 62 3.5 Interventional Cardiology Market, United States, Average Price ($), 2005-2020 64 3.6 Interventional Cardiology Market, United States, Distribution Share by Revenue ($m), 20112012 67 3.7 Interventional Cardiology Market, United States, Company Share by Revenue ($m), 20112012 68 Browse All Reports of This Category @ http://www.radiantinsights.com/catalog/medicaldevices 4 Overview of Key Companies in United States, Interventional Cardiology Market 70 4.1 Boston Scientific Corporation 70 4.1.1 Company Overview 70 4.2 Abbott Laboratories 70 4.2.1 Company Overview 70 4.3 Medtronic, Inc. 71 4.3.1 Company Overview 71 4.4 Cordis Corporation 71 4.4.1 Company Overview 71 4.5 Terumo Corporation 71 4.5.1 Company Overview 71 4.6 Volcano Corporation 72 4.6.1 Company Overview 72 4.7 St. Jude Medical, Inc. 72 4.7.1 Company Overview 72
5 Interventional Cardiology Market Pipeline Products 73 6 Financial Deals Landscape 74 6.1 Acquisition 74 6.1.1 Cardinal Health Completes Acquisition Of AccessClosure For US$320 Million 74 6.1.2 Vanguard Acquires 6.7% Stake In Boston Scientific 76 6.1.3 Fidelity Acquires 10.5% Stake In Boston Scientific, Medical Device Company 77 6.1.4 Maquet Cardiovascular Acquires LAAx, Developer Of Cardiovascular Surgery Device 78 6.1.5 Biosensors International Completes Acquisition Of Spectrum Dynamics For US$72.5 Million 79 6.1.6 Boston Scientific Completes Acquisition Of BridgePoint Medical, Cardiovascular Device Maker 81 6.2 Asset Transactions 83 6.2.1 Vascular Solutions Acquires Venture Catheter From St. Jude Medical For US$3 Million 83 6.3 Debt Offerings 85 6.3.1 Medtronic Completes Public Offering Of Notes Due 2017 For US$250 Million 85 6.3.2 Medtronic Completes Public Offering Of 0.875% Notes Due 2017 For US$250 Million 87 6.3.3 Medtronic Completes Public Offering Of Notes Due 2024 For US$850 Million 89 6.3.4 Medtronic Completes Public Offering Of Notes Due 2044 For US$650 Million 91 6.3.5 Medtronic Completes Public Offering Of Notes Due 2018 For US$1 Billion 93 6.3.6 Medtronic Completes Public Offering Of Notes Due 2043 For US$750 Million 95 6.3.7 Medtronic Completes Public Offering Of Notes Due 2023 For US$1.25 Billion 97 6.4 Merger 99 6.4.1 Emboline And VasoStitch Merge 99 6.5 Partnerships 100 Enquire About Report: http://www.radiantinsights.com/research/united-statesinterventional-cardiology-market-outlook-to-2020 6.5.1 Abiomed Enters Into Licensing Agreement With Opsens For Optical Sensor Technology 100 6.5.2 Coherex Medical Enters Into Distribution Agreement With Biosense Webster 101 6.5.3 Catheter Connections Enters Into Distribution Agreement With Merit Medical Systems For DualCap System 102 6.5.4 Philips Enters Into Distribution Agreement With Corindus For CorPath 200 System 103 6.6 Venture Financing 104 6.6.1 Cardiac Dimensions Raises US$20 Million In Venture Financing 104 6.6.2 Cardiac Dimensions Raises Us$0.38 Million In Venture Financing 105 6.6.3 Cardiac Dimensions Raises US$0.8 Million In Venture Financing 106 6.6.4 MC10 Raises US$20 Million In Venture Financing 107 6.6.5 Cardiac Dimensions Raises US$0.5 Million In Venture Financing 108 6.6.6 Apama Medical Raises US$3.2 Million In Series A-1 Financing Round 109 6.6.7 Cardiva Medical Raises US$3.4 Million In Venture Financing 110 6.6.8 Cardiac Dimensions Raises US$2.4 Million In Venture Financing 111
6.6.9 Cibiem Raises US$10 Million In Series A Financing 113 6.6.10 Cardiac Dimensions Raises US$6 Million In Venture Financing 115 7 Recent Developments 116 7.1 Corporate Communications 116 7.1.1 May 06, 2014: Hansen Medical Appoints Cary Vance as President and CEO 116 7.1.2 Apr 29, 2014: AngioDynamics Names Howard W. Donnelly Chairman of the Board of Directors 116 7.1.3 Mar 18, 2014: Theragenics Appoints Mark Kesti as Vice President of Sales for Galt Medical and NeedleTech Products 117 7.1.4 Mar 03, 2014: Boston Scientific Elects Edward J. Ludwig To Its Board Of Directors 117 7.1.5 Feb 18, 2014: SurModics Announces Changes to Board of Directors 118 7.1.6 Feb 10, 2014: Hansen Medical Announces Appointment of Chris Lowe as Interim CEO; Bruce Barclay to Depart the Company 118 7.1.7 Feb 10, 2014: Hansen Medical Appoints Chris Lowe as Interim CEO 119 7.1.8 Jan 20, 2014: Cardiva Medical Announces Appointment of Randy Hubbell, Chief Commercial Officer 119 7.1.9 Jan 07, 2014: Simbionix Welcomes New Latin and Central American Sales Manager 120 7.1.10 Jan 06, 2014: Boston Scientific Names Craig Thompson, M.D. As New Chief Medical Officer, Interventional Cardiology 120 To Get Sample Copy of Report visit @ http://www.radiantinsights.com/research/unitedstates-interventional-cardiology-market-outlook-to-2020#tabs-4 7.1.11 Dec 16, 2013: Boston Scientific Elects David Roux To Its Board of Directors 121 7.1.12 Dec 11, 2013: AngioDynamics Appoints John Soto Chief Commercial Officer 121 7.1.13 Dec 05, 2013: Anxious Patient Group Calls on NICE to Approve Only Drug Treatment for Ultra-Rare Disease 122 7.1.14 Dec 04, 2013: Cook Medical Names Rob Lyles Executive Vice President 124 7.1.15 Dec 04, 2013: Mark Breedlove Named Vice President of Cook Medical's Peripheral Intervention Clinical Division 124 7.1.16 Nov 21, 2013: Susan Lisa Named Vice President Of Investor Relations Of Boston Scientific 125 7.1.17 Nov 04, 2013: Canbex Therapeutics Commences Phase I Clinical Trial of Lead Product VSN16R as a Potential Treatment for Spasticity in Multiple Sclerosis 125 7.1.18 Oct 24, 2013: Boston Scientific Announces Transition Plan For New Chief Financial Officer 126 7.1.19 Oct 22, 2013: Boston Scientific Eliminates 1500 Jobs 126 7.1.20 Oct 01, 2013: Gretchen Gutman Named Vice President of Public Policy for Cook Group 127 7.1.21 Sep 25, 2013: Accellent Announces the Promotion of Jeremy Friedman to President and Chief Operating Officer for the Cardio & Vascular Business and the Appointment of Richard Johnson as Interim CFO 127 7.1.22 Sep 20, 2013: SurModics Announces Board Changes 128
7.1.23 Aug 22, 2013: Nicky James Named Vice President and Global Leader of Cook Medical Aortic Intervention Clinical Division 128 7.1.24 Aug 02, 2013: China CDC Enters Into R&D Agreement With Aeras Global For TB Vaccine 129 7.1.25 Jul 23, 2013: Dean Schauer, Executive Vice President, Cardio & Vascular Group, Announces Resignation 130 7.1.26 Jul 17, 2013: Marjorie Bowen Appointed to Hansen Medical's Board of Directors 130 7.2 Financial Announcements 131 7.2.1 May 07, 2014: Hansen Medical Reports Recent Business Highlights and First Quarter 2014 Results 131 7.2.2 May 01, 2014: SurModics Reports Second Quarter Fiscal 2014 Results 132 7.2.3 Apr 29, 2014: Boston Scientific Announces Results For First Quarter Ended March 31, 2014 134 7.2.4 Apr 09, 2014: AngioDynamics Reports Fiscal 2014 Third Quarter Financial Results 135 7.2.5 Feb 20, 2014: Hansen Medical Reports Fourth Quarter and Full-Year 2013 Results 137 7.2.6 Feb 18, 2014: Medtronic Reports Third Quarter Earnings 139 About Us Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of Ancillary services such as, research partnerships/ tie-ups and customized research solutions. Media Contact: Michelle Thoras Corporate Sales Specialist, USA Radiant Insights, Inc Phone: 1-415-349-0054 Toll Free: 1-888-202-9519 Email: sales@radiantinsights.com Website: Radiant Insights Visit Our Blog: radiantri.blogspot.com